Cardiovascular Risk Profile of Transgender Women With HIV: A US Health Care Database Study
Shawnbir Gogia(Harvard University), Markella V. Zanni(Harvard University), Virginia A. Triant(Brigham and Women's Hospital), Lauren Stone, Alexandra Coromilas(Harvard University), Tomas G. Neilan(Albert Einstein College of Medicine), Susan Regan(Massachusetts General Hospital), Lindsay T. Fourman(Massachusetts General Hospital)
Cited by 16
Related Papers
Increased Acute Myocardial Infarction Rates and Cardiovascular Risk Factors among Patients with Human Immunodeficiency Virus Disease
|The Journal of Clinical Endocrinology & Metabolism|2007|1.6k
Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
|Journal of the American College of Cardiology|2018|1.5k
Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society
|European Journal of Heart Failure|2020|767
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement
|European Heart Journal|2021|589